Nathalie Cartier-Lacave to Genetic Vectors
This is a "connection" page, showing publications Nathalie Cartier-Lacave has written about Genetic Vectors.
Connection Strength
0.241
-
Cartier N, Hacein-Bey-Abina S, Von Kalle C, Bougn?res P, Fischer A, Cavazzana-Calvo M, Aubourg P. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector]. Bull Acad Natl Med. 2010 Feb; 194(2):255-64; discussion 264-8.
Score: 0.221
-
Zerah M, Piguet F, Colle MA, Raoul S, Deschamps JY, Deniaud J, Gautier B, Toulgoat F, Bieche I, Laurendeau I, Sondhi D, Souweidane MM, Cartier-Lacave N, Moullier P, Crystal RG, Roujeau T, Sevin C, Aubourg P. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates. Hum Gene Ther Clin Dev. 2015 Jun; 26(2):113-24.
Score: 0.020